STAT3 and lung cancer: In lung cancer, it participates in macrophage function control and facilitates the release of proinflammatory chemokines throughout its target colony stimulating factor 1 (CDF1); it can also inhibit STAT3 and AKT signaling (Dang et al., 2016).